EL7.AI
StocksMedium•31 October 2026•
1 min read

STRATEC SE Sells Diatron MI Unit and Raises 2026 Margin Guidance

Key Facts

1STRATEC SE has agreed to sell its subsidiary Diatron MI to a consortium of Indian investors.
2The sale will lead to significant non-cash impairments being recognized in the financial statements.
3The company revised its 2026 adjusted EBIT margin guidance upwards following the transaction.

STRATEC SE has agreed to sell its subsidiary Diatron MI to a consortium of Indian investors for a fixed purchase price of €10.0 million. Benzinga reported that the transaction will result in non-cash impairment losses of €44.1 million in the third quarter of 2026, alongside a negative non-cash deconsolidation effect estimated between €4.0 million and €9.0 million in the fourth quarter.

The company revised its 2026 adjusted EBIT margin guidance upwards to a range of 13.0% to 15.0%, up from the previous forecast of approximately 10.0%. This positive outlook follows the divestment of the loss-making unit, with the company expecting to report sales of €164.9 million and an adjusted EBIT margin of 8.3% for the first nine months of 2026 as of October 30, 2026.

STRATEC is scheduled to publish its quarterly statement for the first nine months of 2026 on November 12, 2026. This upcoming release will provide further clarity on the financial impact of the divestment and the group's adjusted operational trajectory following the separation.